FDA Says K-V Can't Challenge Its Enforcement Decisions
K-V Pharmaceutical Co. can't force the U.S. Food and Drug Administration to crack down on cheaper compounded alternatives of the manufacturer's premature birth prevention drug Makena since FDA enforcement decisions aren't...To view the full article, register now.
Already a subscriber? Click here to view full article